Literature DB >> 16527270

Dietary supplementation of baicalin and quercetin attenuates iron overload induced mouse liver injury.

Yan Zhang1, Hailing Li, Yuling Zhao, Zhonghong Gao.   

Abstract

The introduction of new iron chelating drugs may ultimately improve iron-chelation therapy for patients with iron overload diseases such as thalassaemia and other disorders. In this paper, the in vivo effects of baicalin and quercetin on iron overload induced liver injury were studied on mice. It was found that when iron-dextran induced iron overload mice were fed baicalin or quercetin containing diet (1% w/w) for 45 days, both flavonoids significantly inhibited iron overload induced lipid peroxidation and protein oxidation of liver, decreased hepatic iron and hepatic collagen content, increased the serum non-heme iron level but not serum ferritin level. Flavonoids supplementation also increased the excretion of iron through feces. In vitro study demonstrated that both flavonoids could release iron from ferritin. These results indicate that besides acting as antioxidants, both flavonoids can also release iron from liver and finally excrete it through feces. The present study provides further support for flavonoids to be medicines for iron overload diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527270     DOI: 10.1016/j.ejphar.2006.01.067

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

Review 1.  Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Authors:  Yanwei Li; Jinying Zhao; Christian Hölscher
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

Review 2.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

3.  Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation.

Authors:  Shazaan Hushmendy; Lalithapriya Jayakumar; Amy B Hahn; Devang Bhoiwala; Dipti L Bhoiwala; Dana R Crawford
Journal:  Nutr Res       Date:  2009-08       Impact factor: 3.315

4.  Baicalin alleviates oxidative stress damage in trabecular meshwork cells in vitro.

Authors:  Lei Gong; Jianfeng Zhu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-28       Impact factor: 3.000

5.  Evidence for the role of oxidative stress in the acetylation of histone H3 by ethanol in rat hepatocytes.

Authors:  Mahua Choudhury; Pil-Hoon Park; Daniel Jackson; Shivendra D Shukla
Journal:  Alcohol       Date:  2010-08-12       Impact factor: 2.405

6.  Baicalin Protects Keratinocytes from Toll-like Receptor-4 Mediated DNA Damage and Inflammation Following Ultraviolet Irradiation.

Authors:  Wei Min; Israr Ahmad; Michelle E Chang; Erin M Burns; Qihong Qian; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2015-09-11       Impact factor: 3.421

7.  Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis.

Authors:  Xiao-Dong Peng; Li-Li Dai; Chang-Quan Huang; Chun-Mei He; Li-Juan Chen
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

8.  Iron-binding and anti-Fenton properties of baicalein and baicalin.

Authors:  Carlos A Perez; Yibin Wei; Maolin Guo
Journal:  J Inorg Biochem       Date:  2008-11-19       Impact factor: 4.155

9.  Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease.

Authors:  Carlos A Perez; Yong Tong; Maolin Guo
Journal:  Curr Bioact Compd       Date:  2008-10-01

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.